Most staff are likely aware of the multiple improvement efforts UF Health Jacksonville has successfully implemented to decrease hospital-acquired infections, improve sepsis survival rates and enhance care coordination for patients between inpatient-outpatient transitions. Those efforts have helped decrease 30-day hospital readmissions and improve the aftercare course for patients.
But there are many other initiatives happening quietly behind the scenes that result in safer patient care and improve quality metrics. An example is the unique collaboration between quality data engineers, the pharmacy team and the physician medical staff to enhance warfarin safety.
Warfarin, sold under the brand name Coumadin, is a medication used after certain cardiac and vascular procedures to prevent the formation of blood clots. The patient’s blood is anticoagulated to specific parameters using a laboratory test called the international normalized ratio, or INR. If the INR is too low, the patient is at risk for developing blood clots following the procedure. If the INR is too high, the patient could be at risk for bleeding. Keeping the medication at the correct, narrow range can be challenging.